Dr. Julie Ann Lough shifts focus inward to discuss Beckman Coulter's commitment to One Health and its tools for addressing antimicrobial resistance (AMR). Joining her is Dr. Stephanie Mitchell, Head of Scientific Affairs at Beckman Coulter Microbiology, who brings a unique perspective from her background as a clinical laboratory director before she transitioned to the industry. Dr. Mitchell highlights the importance of microbial identification and antimicrobial susceptibility testing in clinical settings, detailing how these processes inform treatment decisions. They discuss emerging trends in AMR, including rising resistance patterns and factors driving AMR, such as inappropriate antibiotic dosing, empiric treatment practices, and antibiotic use in farm and companion animals. The discussion emphasises the need for diverse stakeholders from clinicians to the pharmaceutical industry to collaborate, reassess treatment regimens, and develop effective diagnostic tools to inform treatment options.

Going Macro on Micro is a podcast series supported by Beckman Coulter that explores emerging themes in microbiology. Subscribe to the podcast wherever you listen to stay up to date with each new episode as it's released.

Beckman Coulter, 2025-15004